Andrew Waltman is an accomplished scientist with extensive experience in the pharmaceutical industry, currently serving as a Senior Scientist at Zoetis Inc. Previously, Andrew held the position of Research Scientist II at Gilead Sciences, where a solid foundation as Research Scientist I was established. Andrew's academic credentials include a Postdoctoral degree in Chemistry from ETH Zürich (2005 - 2008) and a PhD in Chemistry from Caltech (2000 - 2005).
August, 2016 - present